Navigation Links
Indian American Scientist at Work on Multi-targeted Drug

Ananda M. Chakrabarty, an Indian American scientist, has held out a hope of a multi-targeted drug that could help simultaneously treat several diseases including cancer, HIV/AIDS and malaria. //

"I am trying to develop a multi-targeted drug that would work against several diseases like cancer malaria and HIV/AIDS. We have just applied to the US Food and Drug Administration (FDA) and are studying how to move forward," Chakrabarty told the media here Saturday.

Laboratory tests have established that the candidate drug works effectively on breast cancer and melonoma or skin cancer in case of mice, helping in shrinkage of tumour by 65-85 percent.

Malaria tests done in a Chicago laboratory and tests on European, Indian and African strains of HIV done in a Pitsburg laboratory have also provided the hope of a cure through the use of protein produced by pseudomonas aeruginosa, a gram-negative bacterium.

"I am putting my trust on bugs to offer a complete alternative to chemotherapy in case of cancer. I would like to set up an institute in India in partnership to undertake research and develop next generation of products that will target cancers, viruses and parasites with one drug," said Chakrabarty at a lecture organised jointly by the PHD Chamber of Commerce and Industry, the Indo-American Chamber of Commerce and a pharma industry lobby.

In India to address industry bodies during a five-city tour on his vision of India as a knowledge hub, Chakrabarty urged the industry leaders to help nurture innovation.

Expressing keenness to bring his candidate drug to the market after the mandatory clearances and clinical trials, he said it might take three years and about $10 million investment to reach the first phase of human clinical trial to test it for toxicity.

The US FDA may require his newly founded company CDG Therapeutics, which holds exclusive commercial rights to the patent held by the Unive
'"/>




Page: 1 2

Related medicine news :

1. Indian Prime Minister has successful Knee Replacement Surgery
2. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
3. Indian Doctor granted US patent on organ regeneration
4. Heart attack kills one in every 10 Indians
5. Indian Cherry: Richest Source of Vitiamin C
6. Indian Nationals with Foreign Medical Degrees can now practice in India
7. An Indian Bride with signs of SARS
8. Are Indians aware of SARS ?
9. Indians Stay Away from Coke, Pepsi After Toxin Scare
10. Indian pharma industry upbeat on WTO drug deal
11. Indian Treatment for Iraqi Babies

Post Your Comments:
(Date:11/27/2009)... Uploadable USB pedometers may be new, but they,re...ion of advanced accelerometer functionality and au...n over the accuracy of self-reported data. It,s no... participation in a fitness program. ,, CoreHea...liers to integrate this technology. "Our health ch...
(Date:11/27/2009)...FirstCall/ -- The Gymboree Corporation (Nasdaq: G...present at the NASDAQ OMX 23rd Investor Program, w... England, on Wednesday, December 2, 2009, at 11:45...The Gymboree Corporation,s presentation over the I...on "Our Company" at the bottom of the page, go to ...
(Date:11/27/2009)...Newswire-FirstCall/ -- Shamir Optical Industry Ltd...r of innovative products and technology to the oph...d of directors had declared a dividend distributio...imately NIS 37.62 million based on the November 25...imately US$ 0.609 (approximately NIS 2.3 based on ...
(Date:11/27/2009)...economic burdens, study predicts , , FRI...ple with diabetes in the United States is expected...dicts. , That would bring the total by 2034 to ...m 23.7 million today. , , At the same time, the ... the study also warns, rising from an estimated $1...
(Date:11/27/2009)...ual coloring books designed for children ages 2 to... educate - inform parents and children alike on a ...s to ABC,S and a host of other topics. , ...7, 2009 -- Today’s children have enough gadg...r of the day, but one of the oldest and simplest a...
Breaking Medicine News(10 mins):Health News:New USB technology adds accountability and convenience to wellness programs 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2
.... (OTC Bulletin Board: NILT.OB), a biopharmaceutic...diovascular disease, is pleased to announce the,ap... President of,Regulatory Affairs., "We believe Ja...kground will be of great value to Nile as we devel...
...on pharmaceuticals in water, LISLE, Ill., May 8 ...verning drinking water are not strict,enough, acco...he Water,Quality Association. The release of these...te has begun public hearings,to look into the issu...
...ladelphians are expected to join the Lupus WHAT: ...h live entertainment, information and refr...eness about lupus. Live music, giveaways, snacks ...ne., WHY: Although first recognized by medical ...
...,(Nasdaq: DIET ), leveraging the power of the Int... solutions to everyone, today announced that it wi...h 31, 2008, after the U.S.,equity markets close on...ern Time.,Participants may access the call by dial...
...ansmission of patient data from ...PAWTUCKET, R.I., May 8 /PRNewswire/,--InterCompone...nology,solutions and Memorial Hospital of Rhode Is...r Primary Care and Prevention,which tests an eHeal...
... recognizes innovative product launch...8 Mangos, a full-service advertising,agency, took...Advertising,Award competition, sponsored by the He...d from a field of over 4400 entries, Mangos captur...
Other Medicine News:Health News:Jane Moffitt, J.D., LL.M. Named Vice President of Regulatory Affairs of Nile Therapeutics 2Health News:Jane Moffitt, J.D., LL.M. Named Vice President of Regulatory Affairs of Nile Therapeutics 3Health News:Half of Americans Want Stricter Water Quality Laws, Survey Finds 2Health News:5th Annual World Lupus Day Philadelphians Take Part In a Global Rally of Support 2Health News:eDiets.com(R) to Report First Quarter 2008 Results on Tuesday, May 13, 2008 2Health News:InterComponentWare Inc. and Memorial Hospital of Rhode Island Celebrate Milestone 2Health News:InterComponentWare Inc. and Memorial Hospital of Rhode Island Celebrate Milestone 3Health News:InterComponentWare Inc. and Memorial Hospital of Rhode Island Celebrate Milestone 4Health News:Mangos Captures 11 HMR Awards 2
(Date:11/25/2009)...FORD, Mass., Nov. 25 Hol... ), a leading developer, manufacturer and supplier...nd surgical products dedicated to serving the heal... of the Radiological Society of North America (RSN...ugh December 3, 2009 to highlight our new SecurVie...
(Date:11/25/2009)...HILADELPHIA, Nov. 25 ERT...l J. McKelvey, the Company,s President and CEO, an...ident and CFO, are scheduled to present at the 21s...:30 PM EST on December 1, 2009 in New York City, N...resentation by visiting the Company,s corporate we...
(Date:11/25/2009)..., Pa., Nov. 25 BioTrends Research ...TM) : Stelara report, the first in a multi-ph...e launch of Centocor Ortho-Biotech,s Stelara, from...ailability. Each wave of the report provides quan... and qualitative information from a subset of 20. ...
Breaking Medicine Technology:New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 3New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 4ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call 12831 1Younger People Appear More at Risk From New Swine Flu 50334 1Younger People Appear More at Risk From New Swine Flu 50334 2Younger People Appear More at Risk From New Swine Flu 50334 3Younger People Appear More at Risk From New Swine Flu 50334 4TAHU Takes on New Leadership During Vital Time in Health Insurance Industry 50330 1TAHU Takes on New Leadership During Vital Time in Health Insurance Industry 50330 2
...l target in inflammatory indications...ril 15 Roche announced today that it,will acquire...using on,therapeutics targeting PI3-kinase (PI3-K)...role in disease progression and in resistance to,c...dies have demonstrated,the activity of PI3-K inhib...
...rhythms, TAMPA, Fla., April 15 Stinger Systems, ...ro-stun technology today,announced that an animal ...as presented at the 2008 Rocky Mountain Bioenginee...e full paper is available for purchase from the,co...://www.rmbs.org , ABOUT STINGER SYSTEMS, Stinger...
Other Medicine Technology:Roche Gains Access to Important Oncology Target With Potential for Treating Major Cancers Such as Breast and Lung; First Drug Candidate in Phase I Clinical Testing 2Roche Gains Access to Important Oncology Target With Potential for Treating Major Cancers Such as Breast and Lung; First Drug Candidate in Phase I Clinical Testing 3Roche Gains Access to Important Oncology Target With Potential for Treating Major Cancers Such as Breast and Lung; First Drug Candidate in Phase I Clinical Testing 4
Gibco Gentamicin Reagent Solution (50 mg/ml), liquid
LB Agar Plates Magnesium Sulfate-10
LB Agar
L-BROTH, liquid, 5 g NaCl
Medicine Products: